MAPK3 and hepatocellular carcinoma: Hesperidin exhibits anti-cancer effects by inducing cell death in hepatocellular carcinoma HepG2 cells through caspase-independent pathways, primarily by activating the ERK1/2 pathway (Yumnam et al., 2014).